Melanocortin receptors: perspectives for novel drugs
- 1 June 1999
- journal article
- review article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 375 (1-3) , 295-310
- https://doi.org/10.1016/s0014-2999(99)00298-8
Abstract
No abstract availableKeywords
This publication has 106 references indexed in Scilit:
- Selective Antagonist for the Melanocortin 4 Receptor (HS014) Increases Food Intake in Free-Feeding RatsBiochemical and Biophysical Research Communications, 1998
- ART (Protein Product of Agouti-Related Transcript) as an Antagonist of MC-3 and MC-4 ReceptorsBiochemical and Biophysical Research Communications, 1997
- Melanocortins and opiate addictionLife Sciences, 1997
- Evidence Indicating That the TM4, EL2, and TM5 of the Melanocortin 3 Receptor Do Not Participate in Ligand BindingBiochemical and Biophysical Research Communications, 1996
- Major pharmacological distinction of the ACTH receptor from other melanocortin receptorsLife Sciences, 1996
- A Three-Dimensional Model for the Interaction of MSH with the Melanocortin-1 ReceptorBiochemical and Biophysical Research Communications, 1995
- Cloning, expression, and tissue distribution of a fifth melanocortin receptor subtypeNeurochemical Research, 1995
- Evidence for Alternate Points of Attachment for α-MSH and Its Stereoisomer (Nle4,D-Phe7)-α-MSH at the Melanocortin-1 ReceptorBiochemical and Biophysical Research Communications, 1994
- Molecular Cloning, Expression, and Characterization of a Fifth Melanocortin ReceptorBiochemical and Biophysical Research Communications, 1994
- The Neuropeptide Alpha-Melanocyte-Stimulating Hormone Inhibits Experimental Arthritis in RatsNeuroimmunomodulation, 1994